General Information of the Compound
| Compound ID |
CP0441203
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[(3aR,6aS)-2-quinazolin-4-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H23N7O
|
||||||||||||||||||
| Molecular Weight |
425.496
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(c(c1)C(=O)N1C[C@H]2CN(C[C@H]2C1)c1ncnc2ccccc12)-n1nccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H23N7O/c1-16-6-7-22(31-27-8-9-28-31)20(10-16)24(32)30-13-17-11-29(12-18(17)14-30)23-19-4-2-3-5-21(19)25-15-26-23/h2-10,15,17-18H,11-14H2,1H3/t17-,18+
Show/Hide
|
||||||||||||||||||
| InChIKey |
YWGPKWQBLJWLLK-HDICACEKSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1